NL259609A - - Google Patents

Info

Publication number
NL259609A
NL259609A NL259609DA NL259609A NL 259609 A NL259609 A NL 259609A NL 259609D A NL259609D A NL 259609DA NL 259609 A NL259609 A NL 259609A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL259609A publication Critical patent/NL259609A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/816—Enzyme separation or purification by solubility

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
NL259609D 1959-12-31 NL259609A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB56102A DE1115888B (de) 1959-12-31 1959-12-31 Verfahren zur Herstellung eines Streptokinase-Praeparates

Publications (1)

Publication Number Publication Date
NL259609A true NL259609A (fr)

Family

ID=6971216

Family Applications (1)

Application Number Title Priority Date Filing Date
NL259609D NL259609A (fr) 1959-12-31

Country Status (8)

Country Link
US (1) US3138542A (fr)
BE (1) BE598747A (fr)
CH (1) CH426698A (fr)
DE (1) DE1115888B (fr)
FR (2) FR1516703A (fr)
GB (1) GB966672A (fr)
NL (1) NL259609A (fr)
SE (1) SE302440B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645851A (en) * 1967-11-20 1972-02-29 Bochringer Mannheim Gmbh Recovery of glucose oxidase
US20100260674A1 (en) * 2006-12-15 2010-10-14 Concert Pharmaceuticals, Inc. Quinazoline derivatives and methods of treatment
US8343950B2 (en) * 2006-12-15 2013-01-01 Concert Pharmaceuticals, Inc. Quinazoline derivatives and methods of treatment
JP2011516426A (ja) * 2008-03-28 2011-05-26 コンサート ファーマシューティカルズ インコーポレイテッド キナゾリン誘導体および治療方法
EP3260464A1 (fr) * 2012-08-28 2017-12-27 Novartis AG Procede pour la purification d'anticorps au moyen d'alcoos aliphatiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2677643A (en) * 1951-08-03 1954-05-04 American Cyanamid Co Method of purifying labile enzymes contaminated with hemolysin-omicron
US2881114A (en) * 1956-04-25 1959-04-07 Organon Process for the removal of pyrogens from therapeutically active preparations with insoluble phosphate salts
US3016337A (en) * 1959-04-27 1962-01-09 Ortho Pharma Corp Process for depyrogenation and purification of streptokinase
US2997425A (en) * 1959-05-05 1961-08-22 Ortho Pharma Corp Method of purification of streptokinase
US3042586A (en) * 1959-09-29 1962-07-03 Merck & Co Inc Purification of streptokinase

Also Published As

Publication number Publication date
US3138542A (en) 1964-06-23
BE598747A (fr) 1961-07-03
FR1048M (fr) 1962-01-08
FR1516703A (fr) 1968-02-05
DE1115888B (de) 1961-10-26
SE302440B (fr) 1968-07-22
CH426698A (de) 1966-12-31
GB966672A (en) 1964-08-12

Similar Documents

Publication Publication Date Title
AT227430B (fr)
AT221460B (fr)
AT219274B (fr)
FI41261B (fr)
JPS3516677B1 (fr)
AT219912B (fr)
FI40559B (fr)
AT218043B (fr)
AT219811B (fr)
AT213627B (fr)
CS161683B2 (fr)
SE196657C1 (fr)
NL129882C (fr)
BE583407A (fr)
BE580948A (fr)
BE592477A (fr)
BE586035A (fr)
BE582171A (fr)
BE576772A (fr)
BE586027A (fr)
BE586258A (fr)
BE585435A (fr)
BE584355A (fr)
BE576754A (fr)
NL252349A (fr)